Cover Image

5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2

Newborn screening for 5qSMA offers the potential for early, ideally pre-symptomatic, therapeutic intervention. However, limited data exist on the outcomes of individuals with 4 copies of SMN2, and there is no consensus within the SMA treatment community regarding early treatment initiation in this s...

Full description

Saved in:
Bibliographic Details
Main Authors: Vill, Katharina (Author) , Kamm, Christoph (Author) , Mensch, Alexander (Author) , Weiler, Markus (Author) , Ziegler, Andreas (Author)
Format: Article (Journal)
Language:English
Published: 27 February 2024
In: Journal of neurology
Year: 2024, Volume: 271, Issue: 5, Pages: 2787-2797
ISSN:1432-1459
DOI:10.1007/s00415-024-12188-5
Online Access:Resolving-System, kostenfrei, Volltext: https://doi.org/10.1007/s00415-024-12188-5
Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s00415-024-12188-5
Resolving-System, kostenfrei: https://doi.org/10.25673/116898
Get full text
Author Notes:Katharina Vill, Christoph Kamm, Alexander Mensch, Markus Weiler, Andreas Ziegler [und viele weitere] ; SMArtCARE study group

MARC

LEADER 00000caa a2200000 c 4500
001 1885003633
003 DE-627
005 20241205140653.0
007 cr uuu---uuuuu
008 240404s2024 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00415-024-12188-5  |2 doi 
024 7 |a 10.25673/116898  |2 doi 
035 |a (DE-627)1885003633 
035 |a (DE-599)KXP1885003633 
035 |a (OCoLC)1475287264 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Vill, Katharina  |d 1976-  |e VerfasserIn  |0 (DE-588)130003077  |0 (DE-627)486917657  |0 (DE-576)29794486X  |4 aut 
245 1 0 |a 5qSMA  |b standardised retrospective natural history assessment in 268 patients with four copies of SMN2  |c Katharina Vill, Christoph Kamm, Alexander Mensch, Markus Weiler, Andreas Ziegler [und viele weitere] ; SMArtCARE study group 
264 1 |c 27 February 2024 
300 |b Diagramme 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 17.09.2024 
520 |a Newborn screening for 5qSMA offers the potential for early, ideally pre-symptomatic, therapeutic intervention. However, limited data exist on the outcomes of individuals with 4 copies of SMN2, and there is no consensus within the SMA treatment community regarding early treatment initiation in this subgroup. To provide evidence-based insights into disease progression, we performed a retrospective analysis of 268 patients with 4 copies of SMN2 from the SMArtCARE registry in Germany, Austria and Switzerland. Inclusion criteria required comprehensive baseline data and diagnosis outside of newborn screening. Only data prior to initiation of disease-modifying treatment were included. The median age at disease onset was 3.0 years, with a mean of 6.4 years. Significantly, 55% of patients experienced symptoms before the age of 36 months. 3% never learned to sit unaided, a further 13% never gained the ability to walk independently and 33% of ambulatory patients lost this ability during the course of the disease. 43% developed scoliosis, 6.3% required non-invasive ventilation and 1.1% required tube feeding. In conclusion, our study, in line with previous observations, highlights the substantial phenotypic heterogeneity in SMA. Importantly, this study provides novel insights: the median age of disease onset in patients with 4 SMN2 copies typically occurs before school age, and in half of the patients even before the age of three years. These findings support a proactive approach, particularly early treatment initiation, in this subset of SMA patients diagnosed pre-symptomatically. However, it is important to recognize that the register will not include asymptomatic individuals. 
540 |q DE-3  |a Namensnennung 4.0 International  |f CC BY 4.0  |2 cc  |u https://creativecommons.org/licenses/by/4.0/ 
650 4 |a Age of onset 
650 4 |a Molecular therapies 
650 4 |a Neonatal screening 
650 4 |a Pre-symptomatic treatment 
650 4 |a SMA 
650 4 |a SMN2 
650 4 |a Spinal muscular atrophy 
700 1 |a Kamm, Christoph  |e VerfasserIn  |4 aut 
700 1 |a Mensch, Alexander  |d 1987-  |e VerfasserIn  |0 (DE-588)1213394295  |0 (DE-627)1713954044  |4 aut 
700 1 |a Weiler, Markus  |d 1972-  |e VerfasserIn  |0 (DE-588)123920256  |0 (DE-627)706474236  |0 (DE-576)293943079  |4 aut 
700 1 |a Ziegler, Andreas  |d 1979-  |e VerfasserIn  |0 (DE-588)134123530  |0 (DE-627)560894201  |0 (DE-576)278444253  |4 aut 
773 0 8 |i Enthalten in  |t Journal of neurology  |d [Darmstadt] : Steinkopff, 1974  |g 271(2024), 5, Seite 2787-2797  |h Online-Ressource  |w (DE-627)242065155  |w (DE-600)1421299-7  |w (DE-576)065026500  |x 1432-1459  |7 nnas  |a 5qSMA standardised retrospective natural history assessment in 268 patients with four copies of SMN2 
773 1 8 |g volume:271  |g year:2024  |g number:5  |g pages:2787-2797  |g extent:11  |a 5qSMA standardised retrospective natural history assessment in 268 patients with four copies of SMN2 
856 4 0 |u https://doi.org/10.1007/s00415-024-12188-5  |x Resolving-System  |x Verlag  |z kostenfrei  |3 Volltext 
856 4 0 |u https://link.springer.com/article/10.1007/s00415-024-12188-5  |x Verlag  |z kostenfrei  |3 Volltext 
856 4 0 |u https://doi.org/10.25673/116898  |x Resolving-System  |z kostenfrei 
951 |a AR 
992 |a 20240917 
993 |a Article 
994 |a 2024 
998 |g 134123530  |a Ziegler, Andreas  |m 134123530:Ziegler, Andreas  |d 910000  |d 910500  |e 910000PZ134123530  |e 910500PZ134123530  |k 0/910000/  |k 1/910000/910500/  |p 59 
998 |g 123920256  |a Weiler, Markus  |m 123920256:Weiler, Markus  |d 910000  |d 911100  |d 50000  |e 910000PW123920256  |e 911100PW123920256  |e 50000PW123920256  |k 0/910000/  |k 1/910000/911100/  |k 0/50000/  |p 53 
999 |a KXP-PPN1885003633  |e 458063117X 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Katharina Vill, Christoph Kamm, Alexander Mensch, Markus Weiler, Andreas Ziegler [und viele weitere] ; SMArtCARE study group"]},"id":{"eki":["1885003633"],"doi":["10.1007/s00415-024-12188-5","10.25673/116898"]},"person":[{"display":"Vill, Katharina","family":"Vill","role":"aut","given":"Katharina"},{"given":"Christoph","role":"aut","family":"Kamm","display":"Kamm, Christoph"},{"role":"aut","given":"Alexander","family":"Mensch","display":"Mensch, Alexander"},{"display":"Weiler, Markus","family":"Weiler","given":"Markus","role":"aut"},{"display":"Ziegler, Andreas","family":"Ziegler","role":"aut","given":"Andreas"}],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng","ger"],"note":["Gesehen am 14.03.25","Ungezählte Beil.: Supplement"],"id":{"zdb":["1421299-7"],"eki":["242065155"],"issn":["1432-1459"]},"part":{"volume":"271","year":"2024","text":"271(2024), 5, Seite 2787-2797","extent":"11","issue":"5","pages":"2787-2797"},"title":[{"title":"Journal of neurology","title_sort":"Journal of neurology"}],"origin":[{"dateIssuedKey":"1974","dateIssuedDisp":"1974-","publisherPlace":"[Darmstadt] ; Berlin ; Heidelberg [u.a.] ; Darmstadt ; Heidelberg","publisher":"Steinkopff ; Springer ; Steinkopff [u.a.] ; Springer-Medizin-Verl."}],"pubHistory":["Volume 207, issue 1 (March 1974)-"],"disp":"5qSMA standardised retrospective natural history assessment in 268 patients with four copies of SMN2Journal of neurology","physDesc":[{"extent":"Online-Ressource"}],"recId":"242065155"}],"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"27 February 2024"}],"title":[{"subtitle":"standardised retrospective natural history assessment in 268 patients with four copies of SMN2","title_sort":"5qSMA","title":"5qSMA"}],"note":["Gesehen am 17.09.2024"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"recId":"1885003633","physDesc":[{"extent":"11 S.","noteIll":"Diagramme"}]} 
SRT |a VILLKATHAR5QSMA2720 

Similar Items